This PDF is the current document as it appeared on Public Inspection on 09/05/2014 at 08:45 am.
Food and Drug Administration, HHS.
Final rule; correction.Start Printed Page 53134
The Food and Drug Administration (FDA) is correcting a final rule entitled “Postmarketing Safety Reports for Human Drug and Biological Products; Electronic Submission Requirements” that appeared in the Federal Register of June 10, 2014 (79 FR 33072). The document amended FDA's postmarketing safety reporting regulations for human drug and biological products to require that persons subject to mandatory reporting requirements submit safety reports in an electronic format that FDA can process, review, and archive. The document was published with an incorrect RIN number. This document corrects the error.
Effective date: September 8, 2014.Start Further Info
FOR FURTHER INFORMATION CONTACT:
Jean Chung, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 22, Rm. 4466, Silver Spring, MD 20993-0002, 301-796-1874; or Stephen Ripley, Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 71, Rm. 7268, Silver Spring, MD 20993-0002, 240-402-7911.End Further Info End Preamble Start Supplemental Information
In the Federal Register of June 10, 2014, in FR Doc. 2014-13480, the following correction is made:
1. On page 33073, in the third column, the RIN number heading is corrected to read “RIN 0910-AF96”.Start Signature
Dated: September 2, 2014.
Assistant Commissioner for Policy.
[FR Doc. 2014-21266 Filed 9-5-14; 8:45 am]
BILLING CODE 4164-01-P